Test Price
2,800 AED✅ Home Collection Available
FLCN Gene (Birt‑Hogg‑Dubé Syndrome) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين FLCN (متلازمة بيرت-هوغ-دوبي) بتقنية التسلسل الجيني المتقدم (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي 2026
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain & VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post‑Test Clinical Correlation from a DHA‑Licensed Medical Geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
الملخص التنفيذي
دقة تشخيصية تصل إلى 99.9% عبر معالجة بتقنية التسلسل الجيني (NGS) المعتمدة وفق معيار الآيزو 9001:2015. خدمة سحب منزلي على مستوى المستشفيات عبر سلسلة تبريد موثوقة ومسعفين متنقلين. استشارة ما بعد التحليل مع أخصائي وراثة سريرية مرخص من هيئة الصحة بدبي. توثيق تأميني مباشر عبر الواتساب.
Test Overview
The FLCN gene test detects germline mutations associated with Birt‑Hogg‑Dubé (BHD) syndrome, a hereditary condition predisposing to fibrofolliculomas, spontaneous pneumothorax, and renal cell carcinoma. This next‑generation sequencing (NGS) assay analyses the full coding region and flanking intronic boundaries from blood, extracted DNA, or a single drop on an FTA card, enabling precise risk stratification and family screening under DHA‑aligned genetic counselling.
| Feature | Our NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Analytical Sensitivity | 99.9% (complete gene coverage) | ~98% (only targeted exons) |
| Methodology | NGS (Next‑Generation Sequencing) + bioinformatics pipeline | Sanger sequencing of individual amplicons |
| Turnaround Time | 3–4 weeks (optimized workflow) | 4–6 weeks (serial analysis) |
| Regulatory Accreditation | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) + DHA Facility 9834453 | Variable; often lacks UAE‑specific licensing |
Physician Insight & Safety Protocol
“A positive FLCN result is not a diagnosis of cancer, but a powerful tool for surveillance. I urge every patient to interpret these findings together with a clinical geneticist or oncologist – the value lies in the preventive actions that follow, not in the marker alone.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
Safety & Urgent Considerations
- Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
- Exclusion Criteria: This test is not suitable for acute medical emergencies. If you are experiencing sudden severe breathlessness, sharp chest pain, or new‑onset skin lesions with bleeding, proceed directly to the nearest emergency department.
- ER Red Flags: Acute onset of unilateral chest pain with breathlessness (suspect pneumothorax), frank haemoptysis, or a rapidly enlarging facial papule should prompt immediate hospital evaluation.
- Genetic Counselling: A clinical history and a pedigree chart of affected family members are strongly recommended before sample collection.
Patient FAQ & Clinical Guidance
What does a positive FLCN gene test mean for my cancer risk?
A positive result confirms a hereditary predisposition to Birt‑Hogg‑Dubé syndrome, increasing the lifetime risk of renal cell carcinoma to approximately 15–30%; immediate oncological screening and regular renal imaging are recommended.
Can I use a simple finger‑prick blood drop for this test?
Yes, a single drop of blood dried on an FTA card is a fully validated specimen type; our NGS protocol extracts high‑quality genomic DNA without the need for venipuncture, making the collection painless and stable at room temperature.
How quickly will I receive my results, and who interprets them?
Results are reported within 3 to 4 weeks; a DHA‑licensed medical geneticist reviews the data and provides a telephonic post‑test clinical correlation, ensuring you understand the implications and next steps.
Pre‑ Requirement: A genetic counselling session to draw a pedigree chart of family members affected with Birt‑Hogg‑Dubé syndrome is strongly recommended prior to sample submission.
Sample Options: Whole blood, extracted DNA, or one drop of blood on an FTA card.
Turnaround Time: 3 to 4 Weeks | Price: 2800 AED
This service complies with Federal Decree‑Law No. 41 of 2024 (Art. 87), the UAE Child Data Safety (CDS) Law 2026 for minors, and the UAE Personal Data Protection Law (PDPL). Data is processed in ISO 9001:2015 accredited facility (Cert: INT/EGQ/2509DA/3139) under DHA license 9834453.
For home collection (8 AM‑11 PM daily) and insurance queries, WhatsApp: +971545488731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians